CN107467458A - 一种排尿酸防痛风的植物性饮料及其配制方法 - Google Patents
一种排尿酸防痛风的植物性饮料及其配制方法 Download PDFInfo
- Publication number
- CN107467458A CN107467458A CN201710809669.9A CN201710809669A CN107467458A CN 107467458 A CN107467458 A CN 107467458A CN 201710809669 A CN201710809669 A CN 201710809669A CN 107467458 A CN107467458 A CN 107467458A
- Authority
- CN
- China
- Prior art keywords
- uric acid
- gout
- powder
- parts
- beverage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 title claims abstract description 36
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 title claims abstract description 30
- 229940116269 uric acid Drugs 0.000 title claims abstract description 30
- 235000013361 beverage Nutrition 0.000 title claims abstract description 17
- 238000000034 method Methods 0.000 title claims abstract description 13
- 229960002708 antigout preparations Drugs 0.000 title claims abstract description 7
- 150000001875 compounds Chemical class 0.000 title claims abstract description 7
- 239000000843 powder Substances 0.000 claims abstract description 31
- 240000006432 Carica papaya Species 0.000 claims abstract description 29
- 235000009467 Carica papaya Nutrition 0.000 claims abstract description 29
- 244000060011 Cocos nucifera Species 0.000 claims abstract description 16
- 235000013162 Cocos nucifera Nutrition 0.000 claims abstract description 16
- 239000000284 extract Substances 0.000 claims abstract description 12
- 239000002994 raw material Substances 0.000 claims abstract description 12
- 229940094952 green tea extract Drugs 0.000 claims abstract description 9
- 235000020688 green tea extract Nutrition 0.000 claims abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 230000035622 drinking Effects 0.000 claims description 6
- 210000002700 urine Anatomy 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 5
- 238000004659 sterilization and disinfection Methods 0.000 claims description 5
- 235000013353 coffee beverage Nutrition 0.000 claims description 3
- 238000004090 dissolution Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 239000003755 preservative agent Substances 0.000 claims description 2
- 230000002335 preservative effect Effects 0.000 claims description 2
- 239000003651 drinking water Substances 0.000 claims 1
- 235000020188 drinking water Nutrition 0.000 claims 1
- 201000005569 Gout Diseases 0.000 abstract description 11
- 230000008901 benefit Effects 0.000 abstract description 5
- 230000036541 health Effects 0.000 abstract description 5
- 235000008935 nutritious Nutrition 0.000 abstract description 2
- 238000012545 processing Methods 0.000 abstract description 2
- 235000013616 tea Nutrition 0.000 description 17
- 230000000694 effects Effects 0.000 description 14
- 235000013824 polyphenols Nutrition 0.000 description 14
- 150000008442 polyphenolic compounds Chemical class 0.000 description 13
- 235000006264 Asimina triloba Nutrition 0.000 description 10
- 235000013399 edible fruits Nutrition 0.000 description 8
- 238000011282 treatment Methods 0.000 description 8
- 241001499733 Plantago asiatica Species 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 6
- 230000029142 excretion Effects 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 5
- 244000269722 Thea sinensis Species 0.000 description 5
- 230000003796 beauty Effects 0.000 description 5
- 235000016709 nutrition Nutrition 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 201000001431 Hyperuricemia Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 229910001385 heavy metal Inorganic materials 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010030302 Oliguria Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 2
- 235000005487 catechin Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 229950001002 cianidanol Drugs 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- XMOCLSLCDHWDHP-IUODEOHRSA-N epi-Gallocatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-IUODEOHRSA-N 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 231100000753 hepatic injury Toxicity 0.000 description 2
- 235000012907 honey Nutrition 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000003907 kidney function Effects 0.000 description 2
- 230000006651 lactation Effects 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 238000004393 prognosis Methods 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 150000007968 uric acids Chemical class 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- QCHFTSOMWOSFHM-WPRPVWTQSA-N (+)-Pilocarpine Chemical compound C1OC(=O)[C@@H](CC)[C@H]1CC1=CN=CN1C QCHFTSOMWOSFHM-WPRPVWTQSA-N 0.000 description 1
- PFTAWBLQPZVEMU-ZFWWWQNUSA-N (+)-epicatechin Natural products C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-ZFWWWQNUSA-N 0.000 description 1
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 1
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 description 1
- LSHVYAFMTMFKBA-TZIWHRDSSA-N (-)-epicatechin-3-O-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=CC=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-TZIWHRDSSA-N 0.000 description 1
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 1
- OTLLEIBWKHEHGU-UHFFFAOYSA-N 2-[5-[[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy]-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,5-dihydroxy-4-phosphonooxyhexanedioic acid Chemical compound C1=NC=2C(N)=NC=NC=2N1C(C(C1O)O)OC1COC1C(CO)OC(OC(C(O)C(OP(O)(O)=O)C(O)C(O)=O)C(O)=O)C(O)C1O OTLLEIBWKHEHGU-UHFFFAOYSA-N 0.000 description 1
- 208000005223 Alkalosis Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 241000193155 Clostridium botulinum Species 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 229940123457 Free radical scavenger Drugs 0.000 description 1
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 1
- 206010065713 Gastric Fistula Diseases 0.000 description 1
- 241000726221 Gemma Species 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 208000000913 Kidney Calculi Diseases 0.000 description 1
- XMOCLSLCDHWDHP-UHFFFAOYSA-N L-Epigallocatechin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-UHFFFAOYSA-N 0.000 description 1
- 108010028554 LDL Cholesterol Proteins 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 208000028018 Lymphocytic leukaemia Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 235000003805 Musa ABB Group Nutrition 0.000 description 1
- 240000008790 Musa x paradisiaca Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 235000015266 Plantago major Nutrition 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 244000046146 Pueraria lobata Species 0.000 description 1
- 235000010575 Pueraria lobata Nutrition 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 102100028255 Renin Human genes 0.000 description 1
- 108090000783 Renin Proteins 0.000 description 1
- 240000003152 Rhus chinensis Species 0.000 description 1
- 235000014220 Rhus chinensis Nutrition 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 241000607760 Shigella sonnei Species 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000893963 Trichophyton concentricum Species 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 108010092464 Urate Oxidase Proteins 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 208000026816 acute arthritis Diseases 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000002340 alkalosis Effects 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002019 anti-mutation Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 210000001188 articular cartilage Anatomy 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000008953 bacterial degradation Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical group OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 235000020415 coconut juice Nutrition 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 210000003989 endothelium vascular Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- LPTRNLNOHUVQMS-UHFFFAOYSA-N epicatechin Natural products Cc1cc(O)cc2OC(C(O)Cc12)c1ccc(O)c(O)c1 LPTRNLNOHUVQMS-UHFFFAOYSA-N 0.000 description 1
- 235000012734 epicatechin Nutrition 0.000 description 1
- DZYNKLUGCOSVKS-UHFFFAOYSA-N epigallocatechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3cc(O)c(O)c(O)c3 DZYNKLUGCOSVKS-UHFFFAOYSA-N 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 231100000776 exotoxin Toxicity 0.000 description 1
- 239000002095 exotoxin Substances 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 201000006334 interstitial nephritis Diseases 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- NAFSTSRULRIERK-UHFFFAOYSA-M monosodium urate Chemical class [Na+].N1C([O-])=NC(=O)C2=C1NC(=O)N2 NAFSTSRULRIERK-UHFFFAOYSA-M 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 208000007578 phototoxic dermatitis Diseases 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- DBABZHXKTCFAPX-UHFFFAOYSA-N probenecid Chemical compound CCCN(CCC)S(=O)(=O)C1=CC=C(C(O)=O)C=C1 DBABZHXKTCFAPX-UHFFFAOYSA-N 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 230000004144 purine metabolism Effects 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 159000000000 sodium salts Chemical group 0.000 description 1
- 235000013322 soy milk Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000009628 steelmaking Methods 0.000 description 1
- 210000005065 subchondral bone plate Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000001171 synovial bursa Anatomy 0.000 description 1
- 210000001258 synovial membrane Anatomy 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 238000009966 trimming Methods 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/68—Plantaginaceae (Plantain Family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/732—Chaenomeles, e.g. flowering quince
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明是一种采用青木瓜粉、椰子粉、绿茶提取物和车前草提取物配制的可用于排尿酸、防痛风的植物性饮料及其配制方法。本发明的饮料营养丰富、口感良好、安全卫生、饮用方便,适合各类高尿酸人群降低体内尿酸和预防痛风发生,也适合广大消费者养生保健,具有广阔的市场前景和显著的经济效益;其原料来源丰富、加工制作简单,效果良好,易于推广,对于提高全民健康水平具有良好的社会效益。
Description
技术领域
本发明涉及食品饮料领域,具体是一种用青木瓜粉、椰子粉、绿茶提取物和车前草提取物配制的可用于排尿酸、防痛风的植物性饮料及其配制方法。
背景技术
痛风是一种由于嘌呤生物合成代谢增加,尿酸产生过多或因尿酸排泄不良而致血中尿酸升高,尿酸盐结晶沉积在关节滑膜、滑囊、软骨及其他组织中引起的反复发作性炎性疾病。它是由于单钠尿酸盐结晶(MSU)或尿酸在细胞外液形成超饱和状态,使其晶体在组织中沉积而造成的一组异源性疾病。本病以关节液和痛风石中可找到有双折光性的单水尿酸钠结晶为其特点。其临床特征为:高尿酸血症及尿酸盐结晶、沉积所致的特征性急性关节炎、痛风石、间质性肾炎,严重者见关节畸形及功能障碍,常伴尿酸性尿路结石。
人类缺乏尿酸酶,因此尿酸是嘌呤代谢的最终产物。正常人每天大约有1/3的尿酸在肠道细菌降解处理,2/3以原型经肾排泄。体液中的尿酸98%以钠盐形式存在,在37℃,pH值7.4的生理条件下血尿酸的饱和浓度为416.5μmol/L(7.0mg/dl)。成人尿酸池的大小约1200mg,每天机体产生700mg左右尿酸。为维持尿酸平衡,每天经肾脏排泄的尿酸为500mg,经肠道排泄的为200mg,当此平衡被打破时,出现高尿酸血症。实际上,体内尿酸浓度升高时,肠道尿酸分解是增加的。血浆尿酸盐的浓度决定于以下两方面:一是嘌呤的吸收和生成,二是尿酸的分解和排泄。尿酸盐在体液中的溶解度明显地受pH值和温度影响。在正常生理状况下,尿酸盐的溶解度是380.8~404.6μmol/L(6.4~6.8mg/dl),另约有23.8μmol/L(0.4mg/dl)尿酸盐是与蛋白结合,主要是α-1与α2球蛋白。因此,正常体温血浆尿酸盐溶解的最大极限约416.5μmol/L(7.0mg/dl),并以此作为理化指标来判断高尿酸血症。
痛风是一种终身性疾病,无肾功能损害或关节畸形者经有效治疗一般都能维持正常生活和工作,更不会影响寿命。但如果治疗不当,急性关节炎的反复发作可引起较大痛苦。有关节畸形和肾石病者则生活质量会受到一定的影响。肾功能损害严重者,预后较差。
目前所有治疗为对症疗法。切除影响功能活动的痛风结节,并系统治疗。急性痛风发作:卧床休息,秋水仙碱0.5μg/h,直至疼痛缓解或腹泻发生。止痛剂如吲哚美辛100μg/d,2~3天。慢性痛风;低嘌呤饮食,长期应用丙磺舒(羧苯磺胺)1~2g/d,以增加肾脏尿酸排泄。减肥降低体重。未经治疗的痛风性关节炎,其严重程度和发展的速度亦有很大差别。有些患者一生只有几次发作,然而大多数如不治疗,随着发作的反复、频度和程度呈渐进性加重。有人统计痛风患者的寿命较常人短5年,但这完全与个体的情况与治疗的效果有关系。当关节软骨消失,软骨下骨质侵蚀和关节周围组织浸润,造成渐进性病残时,少数重症者在几年之内,即可产生巨大的痛风石和关节的严重破坏。
当今,痛风已遍及全世界,这与社会的发展、经济的进步、教育的程度密切相关。但是不能因为痛风是一个古老的疾病而有所忽视。现在越是先进的国家,发病率越高,特别是经济富裕的国家和地区。因此,痛风的防治及预后还与重视的程度等有关。因此,发明一种具有加速人体尿酸排泄作用的植物性原料配制饮料用于预防痛风发作,是安全有效、经济方便的最佳措施。
发明内容
本发明是一种采用青木瓜粉、椰子粉、绿茶提取物和车前草提取物配制的可用于排尿酸、防痛风的植物性饮料及其配制方法。本发明的饮料营养丰富、口感良好、安全卫生、饮用方便,适合各类高尿酸人群降低体内尿酸和预防痛风发生,也适合广大消费者养生保健,具有广阔的市场前景和显著的经济效益;其原料来源丰富、加工制作简单,效果良好,易于推广,对于提高全民健康水平具有良好的社会效益。
青木瓜粉采用号称“百益果王、果中珍品”的广西特产——青木瓜,采用真空低温脱水、冷冻干燥研磨而成,使木瓜中13种珍贵营养成分保留达98%以上。青木瓜粉全部加工设备采用不锈钢制造,全程的质量控制,符合QS(食品质量安全)标准。
木瓜是抗病保健佳果又称万寿瓜,青木瓜是指未成熟的番木瓜。青木瓜果含水分90%、糖5~6%、少量的酒石酸、枸橼酸、苹果酸等。木瓜内还含有丰富的木瓜酵素、木瓜蛋白酶、凝乳蛋白酶、胡萝卜素、蛋白质、钙盐、苹果酸、柠檬酶和维生素A、B、C及矿物质钙、磷、钾等;并富含十七种以上氨基酸及多种营养元素。
青木瓜粉是用广西纯天然的、未成熟的青色番木瓜果实为原料,采用新一代高科物理技术精制浓缩加工而成的。在生产加工过程中无损失地保留了木瓜的营养成份,浓缩了全部的木瓜精华。本品不添加任何其它成份,属纯天然木瓜果粉,效果与新鲜番木瓜果实具有同等的效果。
木瓜粉具有丰胸、减肥、美容、养颜、护肤嫩白、消食健胃、疏筋通络之功效。对脾胃虚弱、食欲不振、乳汁缺少、关节痛疼、肢体麻木等均有良好效果。女士们常用木瓜粉和葛粉配合食用来丰胸、减肥、美容、养颜,增加皮肤红润有光泽,保持女性青春活力和美丽。木瓜粉特有的木瓜酵素能清心润肺还可以帮助消化、治胃病,它独有木瓜碱具有抗肿瘤、缓解痉挛疼痛之功效,对排肠肌痉挛有明显的治疗作用,对淋巴性白血病细胞具有强烈抗癌活性。木瓜中的凝乳酶有通乳作用,可用于通乳及治疗淋巴性白血病。
现代医学研究表明,椰肉中含有蛋白质、碳水化合物;椰油中含有糖份、维生素B1、维生素B2、维生素C等。纯天然椰子粉由新鲜椰肉榨取的新鲜椰浆,再以喷干法制成粉状。椰子粉富含人体所需的十八种氨基酸、钙、锌、锰、铁、维生素C等营养元素。是迄今为止世界上氨基酸含量最高的天然饮品。
海南椰子的营养价值很高。我国的中医认为,椰肉味甘,性平,入肺、胃经,具有补益脾胃、杀虫消疳的功效;主治暑热烦渴,吐泻伤津,浮肿尿少等病症;椰汁味甘,性温,有生津、利水等功能。其所含的维生素E能保持女性青春活力,丰富的锌可促进少女发育,镁可改善老年人的循环系统。
研究发现经常喝椰子粉还可以均衡人体营养所需,提高人体营养摄入量,增强人体免疫力。
绿茶提取物茶多酚(Green Tea Polyphenols,GTP)是绿茶的主要成分,约占干物质的30%,GTP从茶叶下脚料(茶末、茶片、粗老茶或修剪叶)中提取。由于仅用食品级乙酸乙酯萃取,因而保留了GTP原有结构,产品为淡黄色粉末。主要成分由儿茶素组成,约占GTP总量的60%~80%,其中含4%~6%的表儿茶素(L-EC)、6%~8%的没食子儿茶素(D.L-EC)、10%~15%表没食子儿茶素(L-EGC)、50%~60%表没食子儿茶素没食子酸脂(L-ECG),还有8%~10%的咖啡碱。
GTP结构中富含酚羟基,可提供活泼氢使自由基灭活,而本身被氧化形成的自由基由于邻苯二酚结构而具有较高稳定性。因此,GTP具有清除自由基及抑制脂质过氧化作用。
茶多酚能明显降低高脂血症的血清总胆固醇、甘油三脂、低密度脂蛋白胆固醇含量,同时具有恢复和保护血管内皮功能的作用。茶多酚的降血脂作用也是茶叶能使肥胖者减肥不反弹的主要原因之一。
茶多酚可阻断脂质过氧化过程,提高人体内酶的活性,从而起到抗突变、抗癌症的功效。
茶多酚可抑制肿瘤细胞DNA的合成,诱使突变DNA断裂,因而可抑制肿瘤细胞的合成率,进一步抑制肿瘤的生长的增殖。
茶多酚能杀灭肉毒杆菌及孢子,抑制细菌外毒素的活性。对引起腹泻、呼吸道和皮肤感染的各种病原菌有抗菌作用。茶多酚对引起化脓性感染、烧伤、外伤的金黄色葡萄球菌、变型杆菌有明显的抑制作用。
酒精性肝损伤主要是乙醇引起的自由基损伤,茶多酚作为自由基清除剂,具有抑制酒精性肝损伤的作用。
严重的环境污染对人体健康具有明显的毒害作用,茶多酚对重金属具有强的吸附作用,能与重金属形成络合物而产生沉淀,有利于减轻重金属对人体产生的毒害作用。另外,茶多酚还具有改善肝功能和利尿的作用,因而对生物碱中毒有较好的抗解作用。
茶多酚通过提高人体免疫球蛋白总量并使其维持在高水平,刺激抗体活性的变化,从而提高人的总体免疫能力,并可促进人体的自身调理功能。
茶多酚可用来配制各种茶饮料,应用到各种酒精饮料中,还能抑制豆奶、汽水、果汁等饮料中维生素A和维生素C等多种维生素的破坏,从而保护饮料中的各种营养成分。
车前草茶属车前草科,为多年生短小草本,别名″观世音草″。中国大部分地区都有此草,生长在路边、田头地角,每年6至7月间开花结子,种子称车前子。全草和种子都可入药。车前草茶以前列腺肥大的患者来说,是一道不可或缺的治疗茶饮。
1、对泌尿系统的影响:车前草有一定利尿作用,可使犬、家兔及人的水分排出增多,并增加尿素、尿酸及氯化钠的排出。
2、镇咳、平喘、祛痰作用。
3、抗病原微生物作用:车前草水浸剂在试管内对同心性毛癣菌、羊毛状小芽孢癣菌、星状奴卡菌等有不同程度的抑制作用。平板打洞法证明金黄色葡萄球菌对车前草高度敏感,宋氏痢疾杆菌中度敏感,大肠杆菌、绿脓杆菌、伤寒杆菌轻度敏感。
4、对胃、肠道作用:给巴甫洛夫小胃及胃瘘的狗灌服车前草水提物或浸剂0.5g/kg,对胃液分泌有双向调节作用;对毛果芸香碱所致胃液分泌过多和肾上腺素所致胃液分泌过少,均有对抗作用。
提取部位:全草,规格:5∶1 10∶1 20∶1,性状:棕黄色粉末,网筛孔径:100目,用途:医药保健品,饮料食品添加剂等。
性味归经:寒;甘;归肝、肾、肺、小肠经
功能主治:清热利尿,祛痰,凉血,解毒。用于水肿尿少,热淋涩痛,暑湿泻痢,痰热咳嗽,吐血衄血,痈肿疮毒。
具体实施方式
本发明的原料均采用符合国家食品卫生标准的厂家生产的原料配制,要求生产厂家提供产品质量标准、产品检验报告,确保原料的安全性和一致性。
本发明其特征在于,按照重量份计,青木瓜粉5-8份,椰子粉6-10份,绿茶提取物0.1-0.3份,车前草提取物0.1-0.3份备料,将原料在混合机中混合均匀后,灭菌消毒,密封包装备用。不添加防腐剂。
饮用方法:每次取本发明的饮料粉末10克左右放于杯中,倒入凉白开或其他饮用水100-150毫升,搅拌3-5分钟促其均匀溶解后,即可直接饮用。本发明的饮料安全卫生,根据个人的身体需要不限时间和用量,如有尿意及时小便。也可以按照个人爱好加其他果汁或蜂蜜混合饮用,风味更佳。
下面结合实施例对本发明作进一步说明,以下记载的仅为本发明的优选实施例,当然不能以此来限定本发明之权利范围,因此依本发明权利要求所作的等同变化,仍属本发明所涵盖的范围。
实施例一
按照重量份计,青木瓜粉6份,椰子粉8份,绿茶提取物0.1份,车前草提取物0.1份备料,将原料在混合机中混合均匀后,灭菌消毒,密封包装备用即成。
实施例二
按照重量份计,青木瓜粉6份,椰子粉9份,绿茶提取物0.2份,车前草提取物0.3份备料,将原料在混合机中混合均匀后,灭菌消毒,密封包装备用即成。
实施例三
按照重量份计,青木瓜粉8份,椰子粉10份,绿茶提取物0.3份,车前草提取物0.3份备料,将原料在混合机中混合均匀后,灭菌消毒,密封包装备用即成。
饮用方法:每次取本发明的饮料粉末10克左右放于杯中,倒入凉白开或其他饮用水100-150毫升,搅拌3-5分钟促其均匀溶解后,即可直接饮用。本发明的饮料安全卫生,根据个人的身体需要不限时间和用量,如有尿意及时小便。也可以按照个人的爱好加其他果汁或蜂蜜混合饮用,风味更佳。
最后应说明的是:以上实施例仅用以说明本发明的技术方案,而非对其限制;尽管参照前述实施例对本发明进行了详细的说明,本领域的普通技术人员应当理解:其依然可以对前述各实施例所记载的技术方案进行修改,或者对其中部分技术特征进行等同替换;而这些修改或者替换,并不使相应技术方案的本质脱离本发明各实施例技术方案的精神和范围。
Claims (2)
1.一种排尿酸防痛风的植物性饮料及其配制方法,其特征在于,按照重量份计,青木瓜粉5-8份,椰子粉6-10份,绿茶提取物0.1-0.3份,车前草提取物0.1-0.3份备料,将原料在混合机中混合均匀后,灭菌消毒,密封包装备用。不添加防腐剂。
2.根据权利要求1所述的一种排尿酸防痛风的植物性饮料的饮用方法,其特征在于,每次取本发明的饮料粉末10克左右放于杯中,倒入凉白开或其他饮用水100-150毫升,搅拌3-5分钟促其均匀溶解后,即可直接饮用。根据个人的身体需要不限时间和用量,如有尿意及时小便。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710809669.9A CN107467458A (zh) | 2017-09-01 | 2017-09-01 | 一种排尿酸防痛风的植物性饮料及其配制方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710809669.9A CN107467458A (zh) | 2017-09-01 | 2017-09-01 | 一种排尿酸防痛风的植物性饮料及其配制方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107467458A true CN107467458A (zh) | 2017-12-15 |
Family
ID=60584781
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710809669.9A Pending CN107467458A (zh) | 2017-09-01 | 2017-09-01 | 一种排尿酸防痛风的植物性饮料及其配制方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107467458A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109464563A (zh) * | 2018-12-26 | 2019-03-15 | 广东微量元素生物科技有限公司 | 一种可调节人体尿酸的植物提取组合物及其制备方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103053734A (zh) * | 2012-12-07 | 2013-04-24 | 贺志弘 | 一种不同口味的健康营养型黑茶果茶饮料及制备方法 |
CN103168868A (zh) * | 2011-12-26 | 2013-06-26 | 镇江市丹徒区南山溪园茶叶专业合作社 | 一种有助降低尿酸的保健茶 |
CN104012716A (zh) * | 2014-06-18 | 2014-09-03 | 南京麦思德餐饮管理有限公司 | 一种不含防腐剂的饮料 |
CN105901205A (zh) * | 2016-04-11 | 2016-08-31 | 张智斌 | 一种养生保健茶饮料和预混料的组合及其制备方法 |
CN106266776A (zh) * | 2016-09-18 | 2017-01-04 | 贵阳中医学院 | 一种痛风患者的袋泡茶 |
-
2017
- 2017-09-01 CN CN201710809669.9A patent/CN107467458A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103168868A (zh) * | 2011-12-26 | 2013-06-26 | 镇江市丹徒区南山溪园茶叶专业合作社 | 一种有助降低尿酸的保健茶 |
CN103053734A (zh) * | 2012-12-07 | 2013-04-24 | 贺志弘 | 一种不同口味的健康营养型黑茶果茶饮料及制备方法 |
CN104012716A (zh) * | 2014-06-18 | 2014-09-03 | 南京麦思德餐饮管理有限公司 | 一种不含防腐剂的饮料 |
CN105901205A (zh) * | 2016-04-11 | 2016-08-31 | 张智斌 | 一种养生保健茶饮料和预混料的组合及其制备方法 |
CN106266776A (zh) * | 2016-09-18 | 2017-01-04 | 贵阳中医学院 | 一种痛风患者的袋泡茶 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109464563A (zh) * | 2018-12-26 | 2019-03-15 | 广东微量元素生物科技有限公司 | 一种可调节人体尿酸的植物提取组合物及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102860550B (zh) | 一种具有补肾、壮阳、提高免疫能力的功能饮料及其制备方法 | |
CN103653144B (zh) | 提高免疫力的保健饮料其制备方法 | |
CN104305427A (zh) | 葡萄红茶菌饮料 | |
KR101018065B1 (ko) | 대추를 사용한 건강음료 제조방법 및 이에 의해 제조된 건강음료 | |
CN102987477B (zh) | 一种保健饮料 | |
CN104304578A (zh) | 一种火龙果菌茶 | |
CN106579202A (zh) | 一种含白茶的凤梨西番莲低糖果酱及其制作方法 | |
CN106070626A (zh) | 酸马奶水果饮料及其制备方法 | |
CN100563453C (zh) | 枸杞子奶茶的生产方法 | |
KR20090098024A (ko) | 약주의 제조방법 | |
CN110024926A (zh) | 一种开胃生津金桔饮料及其制备方法 | |
CN105685899A (zh) | 一种健胃消食脆萝卜及其制备方法 | |
CN103005058A (zh) | 一种樱花奶茶及其制造方法 | |
CN104783257A (zh) | 一种山楂青梅复合饮料及其制备工艺 | |
CN104286281A (zh) | 一种西瓜红茶菌饮料 | |
CN107467458A (zh) | 一种排尿酸防痛风的植物性饮料及其配制方法 | |
CN109287919A (zh) | 一种赤豆薏仁草本膏的配方及制备方法 | |
CN102986881A (zh) | 一种菊花奶茶及其制造方法 | |
CN102885364A (zh) | 一种玉米饮料及其制备方法 | |
CN107080136A (zh) | 一种蜂蜜饮料及其制备方法 | |
CN105876557A (zh) | 一种葛根护肝饮料及其制作方法 | |
CN102429274B (zh) | 枇杷果味饮料 | |
CN101113394B (zh) | 枸杞子奶酒的生产方法 | |
CN101113393B (zh) | 红色苦瓜奶酒的生产方法 | |
KR20010008906A (ko) | 무음료 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20171215 |
|
WD01 | Invention patent application deemed withdrawn after publication |